Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Indian J Med Res ; 141(5): 546-55, 2015 May.
Article in English | MEDLINE | ID: mdl-26139771

ABSTRACT

BACKGROUND & OBJECTIVES: The northeastern States of India are co-endemic for Plasmodium falciparum and P. vivax malaria. The transmission intensity is low-to-moderate resulting in intermediate to stable malaria. Malaria control prioritized P. falciparum being the predominant and life threatening infection (>70%). P. vivax malaria remained somewhat neglected. The present study provides a status report of P. vivax malaria in the northeastern States of India. METHODS: Data on spatial distribution of P. vivax from seven northeastern States (Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland and Tripura) were analysed retrospectively from 2008-2013. In addition, cross-sectional malarial surveys were conducted during 1991-2012 in malaria endemic pockets across the States of Assam, Meghalaya, Mizoram and Tripura to ascertain the prevalence of P. vivax in different age groups. RESULTS: Vivax malaria was encountered in all northeastern States but there existed a clear division of two malaria ecotypes supporting ≤30 and >30 per cent of total malaria cases. High proportions of P. vivax cases (60-80%) were seen in Arunachal Pradesh and Nagaland in the north with alpine environment, 42-67 per cent in Manipur, whereas in Assam it varied from 23-31 per cent with subtropical and tropical climate. Meghalaya, Tripura and Mizoram had the lowest proportion of P. vivax cases. Malaria cases were recorded in all age groups but a higher proportion of P. vivax consistently occurred among <5 yr age group compared to P. falciparum (P<0.05). P. vivax cases were recorded throughout the year with peak coinciding with rainy season although transmission intensity and duration varied. INTERPRETATION & CONCLUSIONS: In northeast India, P. vivax is a neglected infection. Estimating the relapsing pattern and transmission dynamics of P. vivax in various ecological settings is an important pre-requisite for planning malaria elimination in the northeastern States.


Subject(s)
Malaria, Vivax/epidemiology , Malaria, Vivax/parasitology , Plasmodium vivax/pathogenicity , Cross-Sectional Studies , Female , Humans , India , Malaria, Vivax/transmission , Male , Retrospective Studies , Seasons
2.
J Prosthodont ; 22(5): 358-61, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23869850

ABSTRACT

PURPOSE: Heat-polymerized acrylic resins are used in dentistry for complete denture fabrication. Despite the polymerization method, conversion of monomer into polymer is often incomplete with free or unreacted residual monomer remaining in the polymerized resin. The aim of this study was to determine the amount of residual monomeric methyl methacrylate (MMA) leaching in the saliva of patients wearing complete dentures in their postinsertion period. MATERIALS AND METHODS: Thirty edentulous participants as first-time complete denture wearers (age 60 to 65 years) were selected. All the prostheses were fabricated using a similar standard technique with a heat-cured acrylic resin denture base material. Saliva samples were collected at time intervals of 1 hour, 1 day, and 3 days postdenture insertion. Participants were asked to discharge saliva every 30 seconds into a pre-weighed screw-capped container for a 5-minute period. MMA levels were measured using high performance liquid chromatography. Data were analyzed by ANOVA and Tukey-HSD. RESULTS: The maximum concentration of monomer released into saliva peaked 1 day after insertion of the complete dentures. The mean (SD) MMA content was 0.04 ± 0.01 (µg/ml) 1 hour after insertion, and 0.3 ± 0.09 (µg/ml), and 0.05 ± 0.01 (µg/ml) on the first and third days postinsertion, respectively. CONCLUSIONS: Although the released monomeric MMA was not at toxic levels, it could potentially sensitize complete denture patients or elicit an allergic reaction. The risk of the residual material as a primary irritant for a sensitizing reaction could be minimized by immersion of the denture in water for 24 hours before insertion.


Subject(s)
Acrylic Resins/analysis , Dental Materials/analysis , Denture, Complete , Methylmethacrylate/analysis , Saliva/chemistry , Acrylic Resins/chemistry , Aged , Chromatography, High Pressure Liquid/methods , Dental Materials/chemistry , Denture Bases , Denture Design , Diffusion , Follow-Up Studies , Hot Temperature , Humans , Methylmethacrylate/chemistry , Middle Aged , Mouth, Edentulous/rehabilitation , Polymerization , Pressure
3.
J Biomed Mater Res B Appl Biomater ; 100(5): 1444-50, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22454327

ABSTRACT

Biocompatibility or tissue compatibility describes the ability of a material to perform with an appropriate host response when applied as intended. Poly-methylmethacrylate (PMMA) based resins are most widely used resins in dentistry, especially in fabrication of dentures and orthodontic appliances. They are considered cytotoxic on account of leaching of various potential toxic substances, most common being residual monomer. Various in vitro and in vivo experiments and cell based studies conducted on acrylic based resins or their leached components have shown them to have cytotoxic effects. They can cause mucosal irritation and tissue sensitization. These studies are not only important to evaluate the long term clinical effect of these materials, but also help in further development of alternate resins. This article reviews information from scientific full articles, reviews, or abstracts published in dental literature, associated with biocompatibility of PMMA resins and it is leached out components. Published materials were searched in dental literature using general and specialist databases, like the PubMED database.


Subject(s)
Polymethyl Methacrylate/adverse effects , Polymethyl Methacrylate/chemistry , Polymethyl Methacrylate/therapeutic use , Resins, Synthetic/adverse effects , Resins, Synthetic/chemistry , Resins, Synthetic/therapeutic use , Humans , PubMed
4.
Lancet ; 377(9761): 252-69, 2011 Jan 15.
Article in English | MEDLINE | ID: mdl-21227500

ABSTRACT

In India, the range and burden of infectious diseases are enormous. The administrative responsibilities of the health system are shared between the central (federal) and state governments. Control of diseases and outbreaks is the responsibility of the central Ministry of Health, which lacks a formal public health department for this purpose. Tuberculosis, malaria, filariasis, visceral leishmaniasis, leprosy, HIV infection, and childhood cluster of vaccine-preventable diseases are given priority for control through centrally managed vertical programmes. Control of HIV infection and leprosy, but not of tuberculosis, seems to be on track. Early success of malaria control was not sustained, and visceral leishmaniasis prevalence has increased. Inadequate containment of the vector has resulted in recurrent outbreaks of dengue fever and re-emergence of Chikungunya virus disease and typhus fever. Other infectious diseases caused by faecally transmitted pathogens (enteric fevers, cholera, hepatitis A and E viruses) and zoonoses (rabies, leptospirosis, anthrax) are not in the process of being systematically controlled. Big gaps in the surveillance and response system for infectious diseases need to be addressed. Replication of the model of vertical single-disease control for all infectious diseases will not be efficient or viable. India needs to rethink and revise its health policy to broaden the agenda of disease control. A comprehensive review and redesign of the health system is needed urgently to ensure equity and quality in health care. We recommend the creation of a functional public health infrastructure that is shared between central and state governments, with professional leadership and a formally trained public health cadre of personnel who manage an integrated control mechanism of diseases in districts that includes infectious and non-infectious diseases, and injuries.


Subject(s)
Communicable Diseases/epidemiology , Public Health , Delivery of Health Care , Health Policy , Humans , India/epidemiology
5.
Lancet ; 376(9754): 1768-74, 2010 Nov 20.
Article in English | MEDLINE | ID: mdl-20970179

ABSTRACT

BACKGROUND: National malaria death rates are difficult to assess because reliably diagnosed malaria is likely to be cured, and deaths in the community from undiagnosed malaria could be misattributed in retrospective enquiries to other febrile causes of death, or vice-versa. We aimed to estimate plausible ranges of malaria mortality in India, the most populous country where the disease remains common. METHODS: Full-time non-medical field workers interviewed families or other respondents about each of 122,000 deaths during 2001-03 in 6671 randomly selected areas of India, obtaining a half-page narrative plus answers to specific questions about the severity and course of any fevers. Each field report was sent to two of 130 trained physicians, who independently coded underlying causes, with discrepancies resolved either via anonymous reconciliation or adjudication. FINDINGS: Of all coded deaths at ages 1 month to 70 years, 2681 (3·6%) of 75,342 were attributed to malaria. Of these, 2419 (90%) were in rural areas and 2311 (86%) were not in any health-care facility. Death rates attributed to malaria correlated geographically with local malaria transmission ratesderived independently from the Indian malaria control programme. The adjudicated results show 205,000 malaria deaths per year in India before age 70 years (55,000 in early childhood, 30,000 at ages 5-14 years, 120,000 at ages 15-69 years); 1·8% cumulative probability of death from malaria before age 70 years. Plausible lower and upper bounds (on the basis of only the initial coding) were 125,000-277,000. Malaria accounted for a substantial minority of about 1·3 million unattended rural fever deaths attributed to infectious diseases in people younger than 70 years. INTERPRETATION: Despite uncertainty as to which unattended febrile deaths are from malaria, even the lower bound greatly exceeds the WHO estimate of only 15,000 malaria deaths per year in India (5000 early childhood, 10 000 thereafter). This low estimate should be reconsidered, as should the low WHO estimate of adult malaria deaths worldwide. FUNDING: US National Institutes of Health, Canadian Institute of Health Research, Li Ka Shing Knowledge Institute.


Subject(s)
Malaria, Falciparum/mortality , Adolescent , Adult , Aged , Child , Child, Preschool , Humans , India/epidemiology , Infant , Infant, Newborn , Malaria, Falciparum/diagnosis , Middle Aged , Rural Population , Young Adult
6.
Popul Health Metr ; 8: 1, 2010 Feb 11.
Article in English | MEDLINE | ID: mdl-20181218

ABSTRACT

BACKGROUND: Malaria in India has been difficult to measure. Mortality and morbidity are not comprehensively reported, impeding efforts to track changes in disease burden. However, a set of blood measures has been collected regularly by the National Malaria Control Program in most districts since 1958. METHODS: Here, we use principal components analysis to combine these measures into a single index, the Summary Index of Malaria Surveillance (SIMS), and then test its temporal and geographic stability using subsets of the data. RESULTS: The SIMS correlates positively with all its individual components and with external measures of mortality and morbidity. It is highly consistent and stable over time (1995-2005) and regions of India. It includes measures of both vivax and falciparum malaria, with vivax dominant at lower transmission levels and falciparum dominant at higher transmission levels, perhaps due to ecological specialization of the species. CONCLUSIONS: This measure should provide a useful tool for researchers looking to summarize geographic or temporal trends in malaria in India, and can be readily applied by administrators with no mathematical or scientific background. We include a spreadsheet that allows simple calculation of the index for researchers and local administrators. Similar principles are likely applicable worldwide, though further validation is needed before using the SIMS outside India.

7.
Environ Monit Assess ; 169(1-4): 397-406, 2010 Oct.
Article in English | MEDLINE | ID: mdl-19888666

ABSTRACT

Phthalic acid esters (PAEs) are well-known ubiquitous environmental pollutants and used as plasticizers for the manufacturing of plastic products. During this exploratory study, an attempt has been made to determine the concentration and distribution of five prominent PAEs, viz. di-methyl phthalate (DMP), di-ethyl phthalate (DEP), di-butyl phthalate (DBP), di-(2-ethylhexyl) phthalate (DEHP), and di-octyl phthalate (DOP) in the sediment samples of Gomti River collected from 30 different locations. Identification and quantification of PAEs were performed by high-performance liquid chromatography. The mean concentration values of DMP, DEP, DBP, DEHP, and DOP were found as 10.54, 4.57, 10.41, 31.61, and 5.16 microg/kg, respectively. Limit of detection and limit of quantification for each PAE were also calculated and found in the ranges of 0.09-0.55 and 0.28-1.67 microg/kg. DEHP was the most frequently detected PAE (present in 93.3% samples); however, DOP was found only in 36.7% samples.


Subject(s)
Environmental Monitoring , Geologic Sediments/chemistry , Phthalic Acids/analysis , Plasticizers/analysis , Water Pollutants, Chemical/analysis , Esters/analysis , Esters/chemistry , India , Phthalic Acids/chemistry , Plasticizers/chemistry , Water Pollutants, Chemical/chemistry
8.
Malar J ; 8: 281, 2009 Dec 08.
Article in English | MEDLINE | ID: mdl-19995437

ABSTRACT

Malaria is endemic in India with an estimated 70-100 million cases each year (1.6-1.8 million reported by NVBDCP); of this 50-55% are Plasmodium vivax and 45-50% Plasmodium falciparum. A recent study on malaria in pregnancy reported from undivided Madhya Pradesh state (includes Chhattisgarh state), that an estimated over 220,000 pregnant women contract malaria infection each year. Malaria in pregnancy caused- abortions 34.5%; stillbirths 9%; and maternal deaths 0.45%. Bulk of this tragic outcome can be averted by following the Roll Back Malaria/WHO recommendations of the use of malaria prevention i.e. indoor residual spraying (IRS)/insecticide-treated bed nets (ITN) preferably long-lasting treated bed nets (LLIN); intermittent preventive therapy (IPT); early diagnosis, prompt and complete treatment using microscopic/malaria rapid diagnostics test (RDT) and case management. High incidence in pregnancy has arisen because of malaria surveillance lacking coverage, lack of age and sex wise data, staff shortages, and intermittent preventive treatment (IPT) applicable in high transmission states/pockets is not included in the national drug policy- an essential component of fighting malaria in pregnancy in African settings. Inadequate surveillance and gross under-reporting has been highlighted time and again for over three decades. As a result the huge problem of malaria in pregnancy reported occasionally by researchers has remained hidden. Malaria in pregnancy may quicken severity in patients with drug resistant parasites, anaemia, endemic poverty, and malnutrition. There is, therefore, urgent need to streamline malaria control strategies to make a difference in tackling this grim scenario in human health.


Subject(s)
Malaria/epidemiology , Plasmodium/isolation & purification , Pregnancy Complications, Parasitic/epidemiology , Abortion, Spontaneous/parasitology , Adult , Aged , Animals , Antimalarials/therapeutic use , Child, Preschool , Cost of Illness , Female , Humans , India/epidemiology , Infant , Infant, Newborn , Malaria/parasitology , Male , Middle Aged , Mosquito Control/methods , Population Surveillance , Pregnancy , Pregnancy Complications, Parasitic/parasitology , Pregnancy Outcome , Prospective Studies , Retrospective Studies
9.
Malar J ; 6: 105, 2007 Aug 07.
Article in English | MEDLINE | ID: mdl-17683630

ABSTRACT

The National Vector Borne Disease Control Programme (NVBDCP) of the Ministry of Health, Government of India is reporting about 2 million parasite positive cases each year, although case incidence is 30-fold or more under-estimated. Forty five to fifty percent of Plasmodium infections are caused by Plasmodium falciparum, the killer parasite. Anti-malaria drug policy (2007) of the NVBDC recommends chloroquine (CQ) as the first line of drug for the treatment of all malarias. In a Primary Health Centre (PHC) reporting 10% or more cases of CQ resistance in P. falciparum, ACT blister pack is recommended and, so far, the policy has been adopted in 261 PHCs of 71 districts. The NVBDCP still depends on CQ to combat malaria and, as a result, P. falciparum has taken deep roots in malaria-endemic regions, causing unacceptable levels of morbidity and mortality. This policy was a subject of criticism in recent Nature and Lancet articles questioning the World Bank's decision to supply CQ to the NVBDCP. Continuation of an outdated drug in the treatment of P. falciparum is counterproductive in fighting drug resistant malaria and in the containment of P. falciparum. Switchover to Artemisinin-based Combination Therapy (ACT) in the treatment of all P. falciparum cases, ban on artemisinin monotherapy and effective vector control (treated nets/efficient insecticide spraying) would be a rational approach to malaria control in India.


Subject(s)
Antimalarials/therapeutic use , Chloroquine/therapeutic use , Malaria/drug therapy , Artemisinins/therapeutic use , Artesunate , Delivery of Health Care , Drug Combinations , Drug Resistance , Humans , India/epidemiology , Malaria/diagnosis , Malaria/economics , Malaria/epidemiology , Preventive Health Services , Pyrimethamine/therapeutic use , Sesquiterpenes/therapeutic use , Socioeconomic Factors , Sulfadoxine/therapeutic use , Time Factors
10.
Am J Trop Med Hyg ; 71(4): 451-6, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15516642

ABSTRACT

Fever surveys were conducted in several districts of the Indian state of Assam to ascertain the prevalence of malaria in relation to vector abundance, entomologic inoculation rates (EIRs), and geographic location of human settlements. Anopheles minimus were incriminated, but their relative abundance and biting rates varied among districts, and no significant correlation was observed between these two indicators (r = 0.43, P = 0.34). Plasmodium falciparum was the predominant parasite species except in two districts where P. vivax was the majority parasite. The EIRs per person/night were 0.46-0.71 in P. falciparum-predominant areas and 0.12 in the district where P. vivax predominated. The correlation of percentage of fever cases positive for malaria infection in each district with the corresponding EIR was not significant (r = 0.6, P = 0.21). Malaria cases were detected in all months of the year but peaked during May-June, which corresponded to the months of heavy rainfall. These were also the months with highest incidence of infection with P. falciparum. Malaria cases were observed in all age groups of both sexes, and there was clustering of cases in villages near the vector-breeding habitat (perennial seepage streams), and foothill villages. However, malaria incidences were consistently lower in villages within 5 km of the nearest health care facility, which were in town areas. The data presented are indicative of low-to-moderate levels of malaria transmission by An. minimus, and would be of value for developing future intervention strategies.


Subject(s)
Anopheles/physiology , Insect Bites and Stings , Malaria, Falciparum/epidemiology , Malaria, Vivax/epidemiology , Animals , Anopheles/classification , Anopheles/parasitology , Female , Humans , India/epidemiology , Malaria, Falciparum/parasitology , Malaria, Falciparum/transmission , Malaria, Vivax/parasitology , Malaria, Vivax/transmission , Male , Plasmodium falciparum/isolation & purification , Plasmodium vivax/isolation & purification , Prevalence , Risk Factors , Seasons
SELECTION OF CITATIONS
SEARCH DETAIL
...